There are 717 resources available
Biomarker-driven approaches to guide clinical care
Presenter: Emanuela Romano
Session: Joint SITC-ESMO Immunotherapy Primer 1
Resources:
Slides
Webcast
Combination approaches to immune checkpoint inhibitors
Presenter: Daniel Shao Weng Tan
Session: Joint SITC-ESMO Immunotherapy Primer 1
Resources:
Slides
Webcast
Live Q&A and live discussion
Presenter: Daniel Weng Tan
Session: Joint SITC-ESMO Immunotherapy Primer 1
Resources:
Webcast
Opening remarks and introduction
Presenter: Ross A. Soo
Session: Pfizer - Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era
Resources:
Webcast
Dissecting the molecular differences and clinical outcomes of EGFR patients with Exon 19 deletion and Exon 21 L858R mutations
Presenter: Yi-Long Wu
Session: Pfizer - Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era
Resources:
Webcast
Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumour Perspective
Presenter: Maurice Pérol
Session: Physicians' Education Resource - Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumour Perspective
Resources:
Webcast
Case based discussion
Presenter: Ullas Batra
Session: Pfizer - Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era
Resources:
Webcast
Panel discussion and closing
Presenter: Nellie Cheah Lay Chin
Session: Pfizer - Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era
Resources:
Webcast
Post session Survey and Q&A Session
Presenter: Masakazu Toi
Session: Physicians' Education Resource - Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan-Tumour Perspective
Resources:
Webcast
234O - Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1
Presenter: Michael Friedlander
Session: Proffered paper session on Gynaecological tumours
Resources:
Abstract
Slides
Webcast